Chelsea Therapeutics shares spiked 8.40 percent on more than 6 million shares traded Wednesday to close at $2.00 a share. The company plans to resubmit a New Drug Application for Northera in late second quarter 2013.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.